Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)Christian F. Singer, Michael Gnant, Muy‐Kheng M. Tea et al.|European Journal of Cancer|2020Cited by 52
Histopathological characterization of ulcerated breast cancer and comparison to their non-ulcerated counterpartsChristine Staudigl, Muy‐Kheng M. Tea, Michaela Bártová et al.|Tumor Biology|2014Cited by 4
The impact of estrogen depletion by aromatase inhibitors on adiponectin serum levels in postmenopausal patients with breast cancer.Georg Pfeiler, Peter Dubsky, Robert Königsberg et al.|Journal of Clinical Oncology|2013Cited by 4
Ki67 to predict RCB0/I after neoadjuvant chemotherapy and endocrine therapy in HER2- breast cancer patients from ABCSG 34.Christian F. Singer, Michael Gnant, Margaretha Rudas et al.|Journal of Clinical Oncology|2018Cited by 2
Circulating tumor cells as an early detection tool for BRCA positive women?Georg Pfeiler, Tanja Fehm, Maria Bernathova et al.|Journal of Clinical Oncology|2016Cited by 0